What is IPF?


Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible, chronic disease of the lungs, which currently affects between 80,000 and 111,000 people in Europe. Every year, additional 30,000-35,000 new patients will be diagnosed with IPF.


About the federation


The European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) brings together European national patient associations committed to defending their vision of equal access to treatment and care for all IPF patients, regardless of geography, socio-economic status or age. Our common view has encouraged us to officially establish the first European IPF and other related disorders federation in July 2016.


Latest blog posts

Latest Tweets